Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-81
Closed -$19.5K 2124
2025
Q4
$19.5K Buy
81
+7
+9% +$1.79K ﹤0.01% 1035
2025
Q3
$20.3K Buy
+74
New +$20.2K ﹤0.01% 1406
2025
Q2
Sell
-311
Closed -$69.6K 2003
2025
Q1
$69.6K Buy
311
+182
+141% +$42.5K 0.02% 659
2024
Q4
$29.5K Sell
129
-290
-69% -$69.8K ﹤0.01% 1017
2024
Q3
$102K Buy
419
+88
+27% +$19.7K 0.03% 424
2024
Q2
$63.4K Buy
331
+242
+272% +$49.1K 0.02% 529
2024
Q1
$17.6K Sell
89
-250
-74% -$45.8K ﹤0.01% 978
2023
Q4
$58.3K Sell
339
-75
-18% -$11.5K 0.01% 274
2023
Q3
$61.2K Buy
414
+12
+3% +$2.17K 0.01% 282
2023
Q2
$87.8K Buy
+402
New +$89.6K 0.03% 162
2023
Q1
Sell
-29
Closed -$6.04K 1250
2022
Q4
$6.04K Buy
+29
New +$6.37K ﹤0.01% 769

Other funds holding RMD

Quarry LP's RMD Position: Q1 2026 in Review

Quarry LP sold out of ResMed (RMD) in Q1 2026, closing a stake of 81 shares — an estimated $19.5K sold.

Quarry LP first reported a position in RMD in Q4 2022 and held it in 11 quarters. The position peaked at $102K in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Quarry LP reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 81 ResMed shares in Q1 2026, an estimated $19.5K.
  • Quarry LP first reported a position in ResMed in Q4 2022 and held it in 11 quarters.
  • Quarry LP's ResMed position peaked at $102K in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.